
|Videos|October 22, 2013
Regulation of Compounding Pharmacies
David G. Miller, RPh, discusses whether and how regulation of compounding pharmacies needs to change.
Advertisement
In this video, shot at the National Community Pharmacists Association 115th Annual Convention in Orlando, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses whether and how regulation of compounding pharmacies needs to change in the wake of the meningitis outbreak caused by tainted steroids produced by the New England Compounding Center.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
2
New CKD Outcome Set Tells Pharmacists What to Measure
3
GLP-1s and the HCM–Sleep Apnea–Obesity Connection
4
The PBM Reform Clock Is Running to 2028—Here's What Independent Pharmacies Should Do
5


































































































